内微生物群 瘤微环境重塑 影响 固体瘤免疫疗法
Jiawen Jia1, Wenwen Gao1, Cong Wang1
1Department of Gynecological Oncology Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China.
Cell death & disease
|December 1, 2025
概括
内微生物群通过重塑瘤微环境来影响癌症免疫疗法的有效性. 准这些微生物有望改善固体瘤治疗反应.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫疗法已经推进了癌症治疗,但固体瘤的应答率仍然很低.
- 瘤微环境 (TME) 极大地影响免疫治疗的疗效.
- 内微生物群越来越多地被认为是TME和治疗反应的关键调节器.
研究的目的:
- 审查内微生物在固体瘤中的作用.
- 探索这些微生物如何影响免疫细胞和TME内的信号传递.
- 讨论微生物群向疗法的潜力,以提高免疫疗法结果.
主要方法:
- 复习多原子分析,确定固体瘤中的细菌特征,包括胰腺管道腺癌 (PDAC).
- 对微生物向治疗的临床前数据的检查.
- 分析内微生物如何与免疫细胞和TME中的信号通路相互作用.
- 研究瘤微卫星状态对微生物影响的影响.
主要成果:
- 细菌特征存在于大量固体瘤中,与治疗耐药性相关的特定联盟.
- 针对微生物群的治疗方法在临床前模型中已经证明有效,增加了瘤清除.
- 内微生物显著影响免疫细胞功能和TME内的信号通路.
- 瘤微卫星状态是瘤内微生物对免疫治疗反应影响的关键决定因素.
结论:
- 内微生物群是固体瘤免疫疗法疗效的关键因素.
- 了解微生物和TME之间的复杂相互作用对于临床翻译至关重要.
- 向瘤内微生物群有可能提高治疗疗效,并预测癌症患者的预后.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


